October 12, 2026 HHS launches new plan to strengthen vaccine injury research, reporting October 12, 2026 Your service area is not your market October 12, 2026 What Gen Z healthcare workers are really looking for October 10, 2026 Americans trust science more than peers around the world, survey shows October 9, 2026 STAT+: Biotech leader, leading lab leak theorist no longer in consideration for top infectious disease role October 9, 2026 STAT+: Hospitals sue – again – to halt Trump administration’s 340B rebate pilot October 9, 2026 STAT+: Pharma’s free lunches for doctors boost inappropriate prescribing, analysis finds October 9, 2026 STAT+: Medicare Advantage star ratings trigger new bonuses, and uncertainty October 9, 2026 STAT+: Life Biosciences share glaucoma study updates for its cellular reprogramming drug October 9, 2026 STAT+: Pharmalittle: We’re reading about a setback for Argenx, Lilly suits over copycat versions of an obesity drug, and more October 9, 2026 How these census changes could threaten public health October 9, 2026 Humana soars, Alignment plummets in 2027 Medicare Advantage star ratings October 9, 2026 STAT+: Will MAHA survive the midterms? October 9, 2026 Opinion: Proposed U.S. census changes could be catastrophic for public health October 9, 2026 Opinion: 50 years ago, my colleagues and I pursued basic research science that became revolutionary October 9, 2026 The fall of Roe dramatically changed abortion access. This researcher used Reddit to capture how October 8, 2026 Trump administration investigates 9 universities for alleged visa fraud October 8, 2026 STAT+: House Democrat seeks to scrap No Surprises Act’s costly arbitration process October 8, 2026 NIH funding uncertainty thwarts U.S. researchers October 8, 2026 A health insurance agency’s journey from pilot to full-time voice AI agent October 8, 2026 Medicare penalizes more hospitals for readmissions October 8, 2026 Healthcare organizations are underprepared for quantum computing threats October 8, 2026 STAT+: The fresh faces that may shake up key Senate committees ahead of midterms October 8, 2026 STAT+: AI for breast cancer risk prediction goes DTC, regulatory cloud over Utah sandbox, and AI psychosis October 8, 2026 FDA says its safety review of abortion pill will continue into next year October 8, 2026 STAT+: Roche goes beyond licensing in deal with Chinese biotech October 8, 2026 Outpatient shift accelerates as hospital margins rebound October 8, 2026 STAT+: Argenx sees unusual setback with failure of late-stage study of drug for autoimmune disease October 8, 2026 STAT+: Pharmalittle: We’re reading about PhRMA suing Trump, biotech frustration over tariffs, and more October 8, 2026 STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines October 8, 2026 The Nobel boys club (again) October 8, 2026 STAT+: Biotech companies are struggling to navigate Trump’s new tariffs October 8, 2026 STAT+: Dozens of Democrats vie for slots on key House health committees October 8, 2026 Opinion: How CMS plans to fix a major flaw in the 340B drug discount program October 8, 2026 Opinion: England and other nations are on the path toward eliminating hepatitis C. Why not the U.S.? October 8, 2026 STAT+: Why this startup is taking its AI to predict breast cancer risk directly to patients October 8, 2026 A mother-daughter quest to find fellow members of an ultra-rare genetic community October 8, 2026 Breast cancer can behave differently in older women. This physician is making more tailored treatments a reality October 8, 2026 STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more October 7, 2026 STAT+: In small trial, optogenetics restores some vision lost to retinitis pigmentosa 1 2 3 … 65 Next Page 2026-03-30
